| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.23 | 5e-07 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.21 | 0.0003 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.075 | 0.1 |